Chardan Capital Trims PT on Esperion (ESPR) Following Q2 Results, TAK-475 Failure Concerning for ETC-1002

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. MU
3. FDX
4. SPY
5. META
6. ABBV
7. ACN
8. NVDA
9. BLZE
10. IBM

Go back to Chardan Capital Trims PT on Esperion (ESPR) Following Q2 Results, TAK-475 Failure Concerning for ETC-1002
ESPERION THERAP (NASDAQ: ESPR) Delayed: 3.16 --0 (-0%)
Previous Close $3.16    52 Week High $30.41 
Open $3.16    52 Week Low $9.40 
Day High $3.16    P/E N/A 
Day Low $3.16    EPS $-21.87 
Volume 115